2seventy bio is an emerging immuno-oncology company focused on developing transformative treatment options for people living with a range of difficult to treat cancers. The company has a robust cell therapy pipeline across a range of hematologic and solid tumors, with a unique scientific approach to delivering therapies that provide significant benefit to cancer patients.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

COM:2SEVENTYBIO

2seventy bio

Last Close

3.16

22/11 21:00

Market Cap

161.99M

Beta: -

Volume Today

483.25K

Avg: -

Analysis Not Available